Plant · Scientific monograph
Betula pendula
Silver birch
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Traditional urinary use
Research overview
Historical use
Birch leaf has an EMA traditional-use conclusion for increasing urine output to support flushing in minor urinary complaints. The monograph covers B. pendula, B. pubescens and hybrids, so evidence is not always attributable to B. pendula alone [1].
Modern research context
EMA found insufficient clinical-trial evidence for a well-established use; its conclusion rests on long-standing traditional use [1]. Other indexed studies include nonclinical or food-beverage investigations and do not establish treatment of urinary infection [2,3].
Adverse effects
EMA reports gastrointestinal symptoms and allergic reactions with frequency unknown [1].
Contraindications
Avoid in birch-leaf/pollen hypersensitivity and in conditions requiring fluid restriction, including severe heart or kidney disease, as specified by EMA [1].
Clinical and phytochemical data
Used part
Leaf, usually as comminuted/powdered material or dry/liquid extract; scope is leaf-specific [1].
Primary active compounds
Mechanism of action
The EMA traditional-use assessment does not establish a clinical mechanism. Nonclinical anti-adhesive findings are not proof of human efficacy [1,2]. The cited human studies do not characterize an active compound or establish constituent-specific activity.
Pharmacokinetics
Absorption
Human PK data for birch-leaf medicinal products were not identified; the beverage study does not establish clinical PK for medicines [2].
Distribution
Not characterized.
Metabolism
Not characterized.
Excretion
No human drug-PK data identified; diuresis is the traditional-use rationale, not a measured medicinal PK endpoint [1].
Safety and interactions
Drug interactions
No species-specific clinical interaction study identified; EMA advises appropriate hydration and lists contraindications [1].
Toxicity
Human long-term toxicity is not established; reported adverse effects are limited to the EMA summary [1].
Special precautions
Pregnancy
EMA indicates use only for adults and adolescents over 12; pregnancy/lactation evidence is insufficient [1].
Lactation
Insufficient data; EMA advises consultation for medicinal use during lactation [1].
Hepatic impairment
No impairment-specific PK or safety data; EMA contraindicates use where fluid restriction is recommended [1].
Renal impairment
Same as hepatic impairment; severe renal disease/fluid restriction is a contraindication [1].
Sources and references
- [1] EMA/HMPC. European Union herbal monograph on Betula pendula Roth, Betula pubescens Ehrh. and hybrids, folium. EMA/482160/2015.
- [2] Roszko M et al. Evaluating birch leaf tea as a functional herbal beverage: Beneficial impact on the urinary tract, and metabolism in human organism. Food Research International. 2024. PMID: 38876582. DOI: 10.1016/j.foodres.2024.114481.
- [3] Emilia Okragla, Milena Chraniuk, Lidia Wolska. Microtox test as a tool to assess antimicrobial properties of herbal infusions used in urinary tract infections. Acta Poloniae Pharmaceutica. 2017;74(3):895–901. PMID: 29513959.